These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9003243)

  • 1. Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12.
    Correale J; McMillan M; Li S; McCarthy K; Le T; Weiner LP
    J Neuroimmunol; 1997 Jan; 72(1):27-43. PubMed ID: 9003243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis.
    Correale J; Gilmore W; McMillan M; Li S; McCarthy K; Le T; Weiner LP
    J Immunol; 1995 Mar; 154(6):2959-68. PubMed ID: 7533188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands.
    Murtaza A; Kuchroo VK; Freeman GJ
    Int Immunol; 1999 Mar; 11(3):407-16. PubMed ID: 10221652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Break of neonatal Th1 tolerance and exacerbation of experimental allergic encephalomyelitis by interference with B7 costimulation.
    Bell JJ; Min B; Gregg RK; Lee HH; Zaghouani H
    J Immunol; 2003 Aug; 171(4):1801-8. PubMed ID: 12902480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients.
    Correale J; McMillan M; McCarthy K; Le T; Weiner LP
    Neurology; 1995 Jul; 45(7):1370-8. PubMed ID: 7542375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis.
    Correale J; Gilmore W; Lopez J; Li SQ; McMillan M; Weiner LP
    Nat Med; 1996 Dec; 2(12):1354-60. PubMed ID: 8946835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
    Windhagen A; Anderson DE; Carrizosa A; Balashov K; Weiner HL; Hafler DA
    J Neuroimmunol; 1998 Nov; 91(1-2):1-9. PubMed ID: 9846813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2.
    Zeinstra E; Wilczak N; De Keyser J
    J Neuroimmunol; 2003 Feb; 135(1-2):166-71. PubMed ID: 12576238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells.
    Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R
    Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
    J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
    Correale J; Rojany M; Weiner LP
    J Neuroimmunol; 1997 Dec; 80(1-2):47-64. PubMed ID: 9413259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth.
    Hausmann MJ; Rogachev B; Weiler M; Chaimovitz C; Douvdevani A
    Kidney Int; 2000 Feb; 57(2):476-86. PubMed ID: 10652024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects.
    Correale J; Arias M; Gilmore W
    J Immunol; 1998 Oct; 161(7):3365-74. PubMed ID: 9759853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects.
    Trotter JL; Pelfrey CM; Trotter AL; Selvidge JA; Gushleff KC; Mohanakumar T; McFarland HF
    J Neuroimmunol; 1998 Apr; 84(2):172-8. PubMed ID: 9628460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
    Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7(+)-transfectant tubular epithelial cells induce T cell anergy, ignorance or proliferation.
    Yokoyama H; Zheng X; Strom TB; Kelley VR
    Kidney Int; 1994 Apr; 45(4):1105-12. PubMed ID: 8007580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis.
    Greer JM; Csurhes PA; Cameron KD; McCombe PA; Good MF; Pender MP
    Brain; 1997 Aug; 120 ( Pt 8)():1447-60. PubMed ID: 9278634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
    Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
    Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.